ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BMK Benchmark Holdings Plc

46.00
1.90 (4.31%)
23 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Benchmark Holdings Plc LSE:BMK London Ordinary Share GB00BGHPT808 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.90 4.31% 46.00 45.20 46.00 45.90 45.90 45.90 18,774 16:35:10
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 169.74M -23.15M -0.0313 -14.66 339.36M
Benchmark Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker BMK. The last closing price for Benchmark was 44.10p. Over the last year, Benchmark shares have traded in a share price range of 33.80p to 48.00p.

Benchmark currently has 739,352,390 shares in issue. The market capitalisation of Benchmark is £339.36 million. Benchmark has a price to earnings ratio (PE ratio) of -14.66.

Benchmark Share Discussion Threads

Showing 976 to 1000 of 1100 messages
Chat Pages: 44  43  42  41  40  39  38  37  36  35  34  33  Older
DateSubjectAuthorDiscuss
26/5/2021
10:13
Our fair value per share of 88p represents a near 50% premium to the current price
edmonda
20/5/2021
14:58
Benchmark Interim Results Presentation 18th May 2021

Trond Williksen, CEO, and Septima Maguire, CFO, run through their results, the progress they are making on the route to commercialising BMK08 and CleanTreat, and how the journey to cash flow break even is progressing.

edmonda
19/5/2021
17:47
Benchmark Holdings (LON:BMK) interim results presentation to analysts, 18.5.21 by Trond Willliksen, CEO, and Septima Maguire, CFO. Good H1 performance with revenue growth +11% and Adjusted EBITDA +13% reflecting a strong performance in Advanced Nutrition and solid trading in Genetics and Health. Significant progress towards commercialisation of BMK08 and Clean Treat. Positive outlook and trading in line with market expectations, with good revenue visibility for the second half.
tomps2
19/5/2021
08:35
listened in - lets say 6 boats in 3 years with a 60% margin and £10m revenue per boat with a capex spend of £2m per boat. well - even i can work out that is transformational for the group. what else can these boats treat fish for too other than sealice is my other question...
edwardt
16/4/2021
11:15
yes but it does show that we need firms like bmk trying to improve the welfare of the fish and the health of the oceans.
edwardt
11/4/2021
18:49
Have you seen the film SEAPIRACY on Nexflex. Puts one off eating fish
tonyhorton
26/3/2021
08:45
hoorah on cleantreat contract. about time. lets hope the regulator can tick their box soon too. lets look forward to more of these wins and enjoy the 60% margins alluded to . they have been a while coming!
edwardt
22/3/2021
20:28
Malcolm Pye? - good luck with guys.
st augustus
03/3/2021
21:01
25/02/2021 07:00 UK Regulatory (RNS & others) OTAQ PLC Non-Executive Director Appointment

OTAQ, the marine technology products and solutions group for the global aquaculture and offshore oil and gas industries, is pleased to announce that Malcolm Pye will join the Board of OTAQ as a Non-Executive Director with immediate effect.

Malcolm founded, and from 1999 to 2019 was Chief Executive of, Benchmark Holdings plc ("Benchmark"), the world's leading aquaculture health, nutrition and genetics business.

Malcolm has over 35 years' experience in international agribusiness through his various roles at Hillsdown Holdings (then HMTF Group), and through building Benchmark from the initial start-up into a major international aquaculture technology business serving the global salmon, shrimp, tilapia and farmed fish industries. Malcolm focused Benchmark's activities on animal health, breeding and genetics, advanced nutrition and knowledge/technology delivery and led the flotation of Benchmark in 2013, maintaining a lead role in investor engagement.

Prior to his founding role at Benchmark, Malcolm gained wide experience in the food sector from his various senior management positions within Hillsdown Holdings, operating in animal breeding, poultry production, feed milling and veterinary services. During this time, he developed extensive experience in breeding and genetics, food production/technology, sales (including account lead responsibilities within the UK / international retail sector with a range of bluechip companies including M&S, Tesco and McDonalds) and strategic M&A as well as holding a main board position within the Group.

Malcolm's work with Hillsdown Holdings in the early to mid-1990's influenced a career-long focus on sustainable food production which formed the basis and inspiration for the creation of Benchmark Holdings.

Alex Hambro, Non-Executive Chairman, commented: "We are really delighted to welcome Malcolm to the Board of OTAQ. Malcolm's experience in, and knowledge of, the global aquaculture industry is unparalleled, and will be of huge benefit to OTAQ as it develops and commercialises additional sustainable technologies and services for the aquaculture farming and producing communities. Our core SealFence acoustic deterrence system has significant opportunities for growth in geographies where Malcolm has built strong long-term relationships. Furthermore, his knowledge of additional farmed species other than salmon will be extremely helpful as we expand our range of products ."

Aside from the information set out in the announcement above, no further information is required to be disclosed pursuant to Listing Rule 9.6.13R.

hedgehog 100
03/3/2021
16:08
ED raised their target from 72 to 88p

www.equitydevelopment.co.uk/research/well-set-ahead-of-key-product-launches

paleje
31/12/2020
12:00
Nice end to the yr!
edwardt
14/12/2020
13:48
Benchmark (BMK) FY20 analyst presentation

Trond Williksen, CEO & Spetima Maguire, CFO present FY20 results to analysts.

Video:

Podcast:

tomps2
04/12/2020
12:39
Benchmark Holdings plc transformed operations during FY20 against the challenging macro conditions brought about by Covid-19, completing a fundamental restructuring via nine disposals in a 12-month period. The latter raising up to £44m, with the closure of non-core or loss-making activities allowing a refocus of the business on aquaculture and a rebasing of the cost structure. Consequently, BMK has reinforced its financial position, boosted liquidity by £50m, and appears very well positioned to execute its growth strategy to achieve commercial returns. This leads us to upgrade our FY 21/22 AEBITDA forecasts and to expect a net profit in FY23.



The Group is uniquely positioned to build selectively on its leading market positions in aquaculture, notably in developing innovative and sustainable products, diversifying its product range, coupled with a strong focus on profitability and from a position of improved balance sheet strength. We also raise our retained value per share from 63p to 72p on our updated forecasts. While the shares have performed well on the back of successful disposals, those gains look fully justified.

edmonda
03/12/2020
20:46
He mentioned peak margins of 60% for bmk08 on up to 75m sales. If that comes off the share price is off to the races!
edwardt
02/12/2020
14:07
guess others who listened in think so too!
edwardt
02/12/2020
12:06
peter george is a no nonsense chap - he gets my vote!
edwardt
30/10/2020
15:21
anyone know why we are flying?
edwardt
15/10/2020
14:56
something fishy going on here?
edwardt
21/9/2020
21:17
The launch of CleanTreat® + BMK08 to combat sea lice is on track.

CleanTreat has not been proven as a commercially viable system and data to demonstrate the system’s efficacy has not been subject to scientific scrutiny. For me, it is a nice story at best, that is all.

BMK08 is I believe based on imidacloprid - is that really the best they could come up with, seriously? Hardly cutting edge is it?

They may well yet go onto exceed predictions but not on the examples you cite, for sure not long term.

st augustus
09/9/2020
10:23
Management at Benchmark Holdings are doing as they promised: the disposals program is nearly complete, raising £44m which boosts financial strength. The launch of CleanTreat® + BMK08 to combat sea lice is on track.

Equity Development keeps its fair value at 63p/share, read new research note here:

edmonda
26/8/2020
16:02
someone wants them.
edwardt
24/8/2020
11:28
guess the city is buying into the focus narrative. hard not to agree that is the way forward. clean treat and salmon genetics should be enough. A mini genus in the making?
edwardt
23/7/2020
11:53
I hate middle men. 4million for selling something worth 16m -completely wrong on my mind. Pen pushers need to be erased. Rant over. Stock up so guess irrelevant
edwardt
23/7/2020
11:39
Massive update.Fire work soon.
36jay
21/7/2020
12:50
For cash you need products that are attractive, and for products in this sector, you need scientists, preferably good ones.
st augustus
Chat Pages: 44  43  42  41  40  39  38  37  36  35  34  33  Older

Your Recent History

Delayed Upgrade Clock